메뉴 건너뛰기




Volumn 129, Issue SUPPL. 2, 2012, Pages

Hemostatic properties of a TFPI antibody

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING FACTOR 9; MONOCLONAL ANTIBODY; SERINE PROTEINASE INHIBITOR; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; TISSUE FACTOR PATHWAY INHIBITOR ANTIBODY; UNCLASSIFIED DRUG;

EID: 84859798949     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.02.030     Document Type: Article
Times cited : (24)

References (16)
  • 1
    • 0025819780 scopus 로고
    • Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma
    • Nordfang O, Valentin S, Beck TC, Hedner U. Inhibition of extrinsic pathway inhibitor shortens the coagulation time of normal plasma and of hemophilia plasma. Thromb Haemost 1991;66(4):464-7.
    • (1991) Thromb Haemost , vol.66 , Issue.4 , pp. 464-467
    • Nordfang, O.1    Valentin, S.2    Beck, T.C.3    Hedner, U.4
  • 2
    • 0025986464 scopus 로고
    • Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas
    • Welsch DJ, Novotny WF, Wun TC. Effect of lipoprotein-associated coagulation inhibitor (LACI) on thromboplastin-induced coagulation of normal and hemophiliac plasmas. Thromb Res 1991;64(2):213-22.
    • (1991) Thromb Res , vol.64 , Issue.2 , pp. 213-222
    • Welsch, D.J.1    Novotny, W.F.2    Wun, T.C.3
  • 3
    • 0029073453 scopus 로고
    • Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A
    • Erhardtsen E, Ezban M, Madsen MT, Diness V, Glazer S, Hedner U, et al. Blocking of tissue factor pathway inhibitor (TFPI) shortens the bleeding time in rabbits with antibody induced haemophilia A. Blood Coagul Fibrinolysis 1995;6(5):388-94.
    • (1995) Blood Coagul Fibrinolysis , vol.6 , Issue.5 , pp. 388-394
    • Erhardtsen, E.1    Ezban, M.2    Madsen, M.T.3    Diness, V.4    Glazer, S.5    Hedner, U.6
  • 4
    • 79951933686 scopus 로고    scopus 로고
    • First 20 years with recombinant FVIIa (NovoSeven)
    • Hedner U, Lee CA. First 20 years with recombinant FVIIa (NovoSeven). Haemophilia 2011;17(1):e172-82.
    • (2011) Haemophilia , vol.17 , Issue.1
    • Hedner, U.1    Lee, C.A.2
  • 5
    • 0032549024 scopus 로고    scopus 로고
    • Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor
    • DOI 10.1074/jbc.273.8.4378
    • Baugh RJ, Broze GJ, Krishnaswamy S. Regulation of extrinsic pathway factor Xa formation by tissue factor pathway inhibitor. J Biol Chem 1998;273(8):4378-86. (Pubitemid 28103174)
    • (1998) Journal of Biological Chemistry , vol.273 , Issue.8 , pp. 4378-4386
    • Baugh, R.J.1    Broze Jr., G.J.2    Krishnaswamy, S.3
  • 6
    • 0030033356 scopus 로고    scopus 로고
    • Inhibitory properties of separate recombinant Kunitz-type-protease- inhibitor domains from tissue-factor-pathway inhibitor
    • Petersen LC, Bjorn SE, Olsen OH, Nordfang O, Norris F, Norris K. Inhibitory properties of separate recombinant Kunitz-type-protease-inhibitor domains from tissuefactor- pathway inhibitor. Eur J Biochem 1996;235(1-2):310-6. (Pubitemid 26048630)
    • (1996) European Journal of Biochemistry , vol.235 , Issue.1-2 , pp. 310-316
    • Petersen, L.C.1    Bjorn, S.E.2    Olsen, O.H.3    Nordfang, O.4    Norris, F.5    Norris, K.6
  • 7
    • 32244438720 scopus 로고    scopus 로고
    • Tissue factor pathway inhibitor: Structure, biology and involvement in disease
    • DOI 10.1002/path.1871
    • Lwaleed BA, Bass PS. Tissue factor pathway inhibitor: structure, biology and involvement in disease. J Pathol 2006;208(3):327-39. (Pubitemid 43210519)
    • (2006) Journal of Pathology , vol.208 , Issue.3 , pp. 327-339
    • Lwaleed, B.A.1    Bass, P.S.2
  • 9
    • 38349145384 scopus 로고    scopus 로고
    • Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A
    • Prasad S, Lillicrap D, Labelle A, Knappe S, Keller T, Burnett E, et al. Efficacy and safety of a new-class hemostatic drug candidate, AV513, in dogs with hemophilia A. Blood 2008;111(2):672-9.
    • (2008) Blood , vol.111 , Issue.2 , pp. 672-679
    • Prasad, S.1    Lillicrap, D.2    Labelle, A.3    Knappe, S.4    Keller, T.5    Burnett, E.6
  • 10
    • 79956299608 scopus 로고    scopus 로고
    • Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor
    • Waters EK, Genga RM, Schwartz MC, Nelson JA, Schaub RG, Olson KA, et al. Aptamer ARC19499 mediates a procoagulant hemostatic effect by inhibiting tissue factor pathway inhibitor. Blood 2011;117(20):5514-22.
    • (2011) Blood , vol.117 , Issue.20 , pp. 5514-5522
    • Waters, E.K.1    Genga, R.M.2    Schwartz, M.C.3    Nelson, J.A.4    Schaub, R.G.5    Olson, K.A.6
  • 11
    • 80052415230 scopus 로고    scopus 로고
    • Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: Changing clot size by targeting extrinsic pathway initiation
    • Parunov LA, Fadeeva OA, Balandina AN, Soshitova NP, Kopylov KG, Kumskova MA, et al. Improvement of spatial fibrin formation by the anti-TFPI aptamer BAX499: changing clot size by targeting extrinsic pathway initiation. J Thromb Haemost 2011;9(9):1825-34.
    • (2011) J Thromb Haemost , vol.9 , Issue.9 , pp. 1825-1834
    • Parunov, L.A.1    Fadeeva, O.A.2    Balandina, A.N.3    Soshitova, N.P.4    Kopylov, K.G.5    Kumskova, M.A.6
  • 14
    • 0024991650 scopus 로고
    • Regulation of coagulation by a multivalent Kunitz-type inhibitor
    • DOI 10.1021/bi00485a001
    • Broze GJ, Girard TJ, Novotny WF. Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochemistry 1990;29(33):7539-46. (Pubitemid 20279168)
    • (1990) Biochemistry , vol.29 , Issue.33 , pp. 7539-7546
    • Broze Jr., G.J.1    Girard, T.J.2    Novotny, W.F.3
  • 15
    • 0026440727 scopus 로고
    • Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa
    • Day KC, Welsch DJ. Bacterial expression, purification, and partial characterization of amino acids 94-155 of human tissue factor pathway inhibitor (TFPI) as an inhibitor of blood coagulation factor Xa. Thromb Res 1992;68(4-5):369-81.
    • (1992) Thromb Res , vol.68 , Issue.4-5 , pp. 369-381
    • Day, K.C.1    Welsch, D.J.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.